Composite Resins

Publication Title: 
Malaria Journal

BACKGROUND: Severe malaria results in over a million deaths every year, most of them in children aged less than five years and living in sub-Saharan Africa. Injectable artesunate (AS) was recommended as initial treatment for severe malaria by WHO in 2006. The Walter Reed Army Institute of Research (WRAIR) has been developing a novel good manufacturing practice (GMP) injection of AS, which was approved by the US FDA for investigational drug use and distribution by the CDC.

Author(s): 
Miller, Robert Scott
Li, Qigui
Cantilena, Louis R.
Leary, Kevin J.
Saviolakis, George A.
Melendez, Victor
Smith, Bryan
Weina, Peter J.
Subscribe to RSS - Composite Resins